Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Karsten M. Strauss(Hertie Institute for Clinical Brain Research), Rejko Krüger(Centre Hospitalier de Luxembourg), Sabine Kautzmann(University of Tübingen), Jörg B. Schulz(Forschungszentrum Jülich), Thomas Müller(Ruhr University Bochum), Hélène Plun‐Favreau(National Hospital for Neurology and Neurosurgery), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Olaf Rieß(University of Tübingen), Thomas Gasser(Hertie Institute for Clinical Brain Research), Zbginiew Wszolek, Frank P. Marx(University of Tübingen), Antje Bornemann(University Children's Hospital Tübingen), Hartwig Wolburg(University of Tübingen), L. Miguel Martins(University of Cambridge), Julian Downward(The Francis Crick Institute)
Cited by 566
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
|Nature|1984|2.5k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k